Both LAG3 and TIM3 are frequently found to be co-expressed with PD-1 on inactive TILs and dual ICB managed to effectively reverse tumor specific T cell anergy more than monotherapy in preclinical models [42]. This evidence concerns the gene LAG3 and neoplasm.